Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 1
1991 1
1998 2
1999 1
2000 1
2001 1
2006 2
2007 1
2014 1
2018 1
2020 3
2021 4
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
ERS guidelines on the diagnosis and treatment of chronic cough in adults and children.
Morice AH, Millqvist E, Bieksiene K, Birring SS, Dicpinigaitis P, Domingo Ribas C, Hilton Boon M, Kantar A, Lai K, McGarvey L, Rigau D, Satia I, Smith J, Song WJ, Tonia T, van den Berg JWK, van Manen MJG, Zacharasiewicz A. Morice AH, et al. Among authors: domingo ribas c. Eur Respir J. 2020 Jan 2;55(1):1901136. doi: 10.1183/13993003.01136-2019. Print 2020 Jan. Eur Respir J. 2020. PMID: 31515408 Free PMC article.
Mepolizumab treatment in patients with severe eosinophilic asthma.
Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, Humbert M, Katz LE, Keene ON, Yancey SW, Chanez P; MENSA Investigators. Ortega HG, et al. N Engl J Med. 2014 Sep 25;371(13):1198-207. doi: 10.1056/NEJMoa1403290. Epub 2014 Sep 8. N Engl J Med. 2014. PMID: 25199059 Free article. Clinical Trial.
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW, Chanez P, Menzella F, Canonica GW, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, McDermott L, Garcia Gil E, Zangrilli JG; ANDHI study investigators. Harrison TW, et al. Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22. Lancet Respir Med. 2021. PMID: 33357499 Clinical Trial.
Is asthma control more than just an absence of symptoms? An expert consensus statement.
Canonica GW, Spanevello A, de Llano LP, Domingo Ribas C, Blakey JD, Garcia G, Inoue H, Dalcolmo M, Yang D, Mokashi S, Kurne A, Butta AK. Canonica GW, et al. Among authors: domingo ribas c. Respir Med. 2022 Oct;202:106942. doi: 10.1016/j.rmed.2022.106942. Epub 2022 Aug 4. Respir Med. 2022. PMID: 36096072 Free article. Review.
[Primary ciliary dyskinesia].
Domingo Ribas C, Roig Cutillas J. Domingo Ribas C, et al. Med Clin (Barc). 1991 Jun 22;97(4):144-6. Med Clin (Barc). 1991. PMID: 1895800 Review. Spanish. No abstract available.
What's New in the 2022 Consensus for Severe Asthma in Adults.
Alvarez-Gutiérrez FJ, Blanco-Aparicio M, Casas-Maldonado F, Plaza V, González-Barcala FJ, Carretero-Gracia JÁ, Castilla-Martínez M, Cisneros C, Diaz-Pérez D, Domingo-Ribas C, Martínez-Moragon E, Muñoz X, Padilla-Galo A, Perpiña-Tordera M, Soto-Campos G. Alvarez-Gutiérrez FJ, et al. Among authors: domingo ribas c. Arch Bronconeumol. 2023 Mar;59(3):190-192. doi: 10.1016/j.arbres.2022.09.012. Epub 2022 Sep 28. Arch Bronconeumol. 2023. PMID: 36243640 English, Spanish. No abstract available.
Monoclonal antibody treatment for severe uncontrolled asthma in Spain: analytical map.
Casas-Maldonado F, Álvarez-Gutiérrez FJ, Blanco-Aparicio M, Domingo-Ribas C, Cisneros-Serrano C, Soto-Campos G, Román-Bernal B, González-Barcala FJ. Casas-Maldonado F, et al. Among authors: domingo ribas c. J Asthma. 2022 Oct;59(10):1997-2007. doi: 10.1080/02770903.2021.1978483. Epub 2021 Sep 17. J Asthma. 2022. PMID: 34503370
23 results